HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AbbVie
SAN FRANCISCO, April 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges AbbVie Inc. (NYSE: ABBV) investors who suffered significant losses to submit your...
Hagens Berman Reed Kathrein Abbvie Inc Plaintiff Deadline Securities Fraud Class Action Hagens Berman Sobol Shapiro Llp
Source: globenewswire.com